Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5730)
All Articles published online
|
Mar 7, 2006 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Romanelli RG, Villa GL, Barletta G, Vizzutti F, Lanini F, Arena U, Boddi V, Tarquini R, Pantaleo P, Gentilini P, Laffi G. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: An unblinded randomized trial. World J Gastroenterol 2006; 12(9): 1403-1407 [PMID: 16552809 DOI: 10.3748/wjg.v12.i9.1403] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i9/1403.htm |
| Number | Citing Articles |
| 1 |
Leire Leache, Marta Gutiérrez‐Valencia, Luis Carlos Saiz, Juan Uriz, Federico Bolado, José Antonio García‐Erce, Lorenzo Cantarelli, Juan Erviti. Letter: Albumin—Does formulation matter? Authors' reply. Alimentary Pharmacology & Therapeutics 2023; 57(12): 1484 doi: 10.1111/apt.17546
|
| 2 |
Aziza Ajlan, Waleed K. Al-hamoudi, Hussein Elsiesy. Ascites - Physiopathology, Treatment, Complications and Prognosis. 2017; doi: 10.5772/intechopen.70544
|
| 3 |
Danielle Adebayo, Shuet Fong Neong, Florence Wong. Ascites and Hepatorenal Syndrome. Clinics in Liver Disease 2019; 23(4): 659 doi: 10.1016/j.cld.2019.06.002
|
| 4 |
Young Seok Kim. Ascites, Hepatorenal Syndrome and Spontaneous Bacterial Peritonitis in Patients with Portal Hypertension. The Korean Journal of Gastroenterology 2010; 56(3): 168 doi: 10.4166/kjg.2010.56.3.168
|
| 5 |
Satoshi Yasumura, Masanori Matsumoto, Shigeyoshi Makino, Shuichi Kino, Asashi Tanaka, Takehiro Kohno, Akito Nozaki, Koji Matsuzaki, Yuji Yonemura, Tadashi Matsushita. EVIDENCE-BASED GUIDELINES FOR THE USE OF ALBUMIN PRODUCTS (SECOND EDITION). Japanese Journal of Transfusion and Cell Therapy 2018; 64(6): 700 doi: 10.3925/jjtc.64.700
|
| 6 |
Zhen Chen, Yang He, Bo Shi, Daichang Yang. Human serum albumin from recombinant DNA technology: Challenges and strategies. Biochimica et Biophysica Acta (BBA) - General Subjects 2013; 1830(12): 5515 doi: 10.1016/j.bbagen.2013.04.037
|
| 7 |
Paolo Caraceni, Oliviero Riggio, Paolo Angeli, Carlo Alessandria, Sergio Neri, Francesco G Foschi, Fabio Levantesi, Aldo Airoldi, Sergio Boccia, Gianluca Svegliati-Baroni, Stefano Fagiuoli, Roberto G Romanelli, Raffaele Cozzolongo, Vito Di Marco, Vincenzo Sangiovanni, Filomena Morisco, Pierluigi Toniutto, Annalisa Tortora, Rosanna De Marco, Mario Angelico, Irene Cacciola, Gianfranco Elia, Alessandro Federico, Sara Massironi, Riccardo Guarisco, Alessandra Galioto, Giorgio Ballardini, Maria Rendina, Silvia Nardelli, Salvatore Piano, Chiara Elia, Loredana Prestianni, Federica Mirici Cappa, Lucia Cesarini, Loredana Simone, Chiara Pasquale, Marta Cavallin, Alida Andrealli, Federica Fidone, Matteo Ruggeri, Andrea Roncadori, Maurizio Baldassarre, Manuel Tufoni, Giacomo Zaccherini, Mauro Bernardi, Marco Domenicali, Ferdinando A Giannone, Manuela Merli, Stefania Gioia, Silvano Fasolato, Antonietta Sticca, Daniela Campion, Alessandro Risso, Giorgio M Saracco, Daniela Maiorca, Agostino Rizzotto, Arianna Lanzi, Elga Neri, Anna Visani, Antonio Mastroianni, Alberto B Alberti, Chiara Mazzarelli, Marcello Vangeli, Marco Marzioni, Francesca Capretti, Alba Kostandini, Giulia Magini, Maria Colpani, Giacomo Laffi, Tommaso Gabbani, Maria Marsico, Marianna Zappimbulso, Josè Petruzzi, Vincenza Calvaruso, Giovanni Parrella, Nicola Caporaso, Francesco Auriemma, Maria Guarino, Fabio Pugliese, Antonio Gasbarrini, Pietro Leo, Francesco De Leonardis, Alessandra Pecchioli, Piera Rossi, Giovanni Raimondo, Elisa Negri, Marcello Dallio, Carmelina Loguercio, Dario Conte, Natascia Celli, Roberto Bringiotti, Nicola M Castellaneta, Francesco Salerno. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. The Lancet 2018; 391(10138): 2417 doi: 10.1016/S0140-6736(18)30840-7
|
| 8 |
Yuan Gao, Xin Liu, Yunyi Gao, Meili Duan, Bing Hou, Yu Chen. Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons. Gut and Liver 2024; 18(6): 934 doi: 10.5009/gnl240038
|
| 9 |
Florence Wong. Management of ascites in cirrhosis. Journal of Gastroenterology and Hepatology 2012; 27(1): 11 doi: 10.1111/j.1440-1746.2011.06925.x
|
| 10 |
Andrea Gallo, Cristina Dedionigi, Chiara Civitelli, Anna Panzeri, Chiara Corradi, Alessandro Squizzato. Optimal management of cirrhotic ascites: A review for internal medicine physicians. Journal of Translational Internal Medicine 2020; 8(4): 220 doi: 10.2478/jtim-2020-0035
|
| 11 |
Qi-Ci Wu, Dong-Qiang Lin, Wei Shi, Qi-Lei Zhang, Shan-Jing Yao. A mixed-mode resin with tryptamine ligand for human serum albumin separation. Journal of Chromatography A 2016; 1431: 145 doi: 10.1016/j.chroma.2015.12.066
|
| 12 |
Bahaa Eldeen Senousy, Peter V Draganov. Evaluation and management of patients with refractory ascites. World Journal of Gastroenterology 2009; 15(1): 67-80 doi: 10.3748/wjg.15.67
|
| 13 |
Rita Garcia-Martinez, Paolo Caraceni, Mauro Bernardi, Pere Gines, Vicente Arroyo, Rajiv Jalan. Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 2013; 58(5): 1836 doi: 10.1002/hep.26338
|
| 14 |
Xia He, XiaoYun Liu, SongQing Peng, Zhong Han, Jianjiang Shen, Ming Cai, Juliana Melgaço. Association of Low High-Density Lipoprotein Cholesterol Levels with Poor Outcomes in Hepatitis B-Associated Decompensated Cirrhosis Patients. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/9927330
|
| 15 |
Wen-Ning Chu, Qi-Ci Wu, Qi-Lei Zhang, Shan-Jing Yao, Dong-Qiang Lin. High-Throughput Process Development for Recombinant Human Serum Albumin Separation from Pichia pastoris Broth with Mixed-Mode Chromatography. Industrial & Engineering Chemistry Research 2019; 58(8): 3238 doi: 10.1021/acs.iecr.8b04596
|
| 16 |
Bruce A. Runyon. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010; : 1517 doi: 10.1016/B978-1-4160-6189-2.00091-3
|
| 17 |
Elsa Solà, Cristina Solé, Macarena Simón-Talero, Marta Martín-Llahí, José Castellote, Rita Garcia-Martínez, Rebeca Moreira, Maria Torrens, Francisca Márquez, Núria Fabrellas, Gloria de Prada, Patrícia Huelin, Eva Lopez Benaiges, Meritxell Ventura, Marcela Manríquez, André Nazar, Xavier Ariza, Pilar Suñé, Isabel Graupera, Elisa Pose, Jordi Colmenero, Marco Pavesi, Mónica Guevara, Miquel Navasa, Xavier Xiol, Joan Córdoba, Victor Vargas, Pere Ginès. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. Journal of Hepatology 2018; 69(6): 1250 doi: 10.1016/j.jhep.2018.08.006
|
| 18 |
Joana R. Carvalho, Mariana Verdelho Machado. New Insights About Albumin and Liver Disease. Annals of Hepatology 2018; 17(4): 547 doi: 10.5604/01.3001.0012.0916
|
| 19 |
Christian J. Wiedermann. Reducing Mortality in Acute Kidney Injury. 2016; : 133 doi: 10.1007/978-3-319-33429-5_16
|
| 20 |
E. G. Malaeva. MANAGEMENT OF ASCITES IN CIRRHOSIS. Health and Ecology Issues 2012; (3): 28 doi: 10.51523/2708-6011.2012-9-3-6
|
| 21 |
Carlos TERRA, Elisabet VIAYNA, Laura AYZIN, Cristina FUSTER, Susana ACEITUNO, Claudio TAFLA. ALBUMIN VERSUS STANDARD MEDICAL TREATMENT IN BRAZILIAN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS. Arquivos de Gastroenterologia 2023; 60(3): 356 doi: 10.1590/s0004-2803.230302023-65
|
| 22 |
Mauro Bernardi, Paolo Caraceni, Roberta J. Navickis, Mahlon M. Wilkes. Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials. Hepatology 2012; 55(4): 1172 doi: 10.1002/hep.24786
|
| 23 |
W. Ray Kim, Karthik Raghunathan, Greg S. Martin, E. Anne Davis, Navreet Sandhu Sindhwani, Santosh Telang, Kunal Lodaya, Haruki Komatsu. Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. BioMed Research International 2024; 2024(1) doi: 10.1155/2024/6673823
|
| 24 |
Guruprasad P Aithal, Naaventhan Palaniyappan, Louise China, Suvi Härmälä, Lucia Macken, Jennifer M Ryan, Emilie A Wilkes, Kevin Moore, Joanna A Leithead, Peter C Hayes, Alastair J O"Brien, Sumita Verma. Guidelines on the management of ascites in cirrhosis. Gut 2021; 70(1): 9 doi: 10.1136/gutjnl-2020-321790
|
| 25 |
Giacomo Zaccherini, Manuel Tufoni, Mauro Bernardi. <p>Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature</p>. Hepatic Medicine: Evidence and Research 2020; : 153 doi: 10.2147/HMER.S264231
|
| 26 |
Ming Cai, Zhong Han, Xia He, JinFei Zhang, Marcelo A. Soares. Usefulness of International Normalized Ratio to Albumin Ratio for Evaluation of Mortality in Hepatitis B Virus-Associated Decompensated Cirrhosis. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6664574
|
| 27 |
Wesley Leung, Florence Wong. Medical management of ascites. Expert Opinion on Pharmacotherapy 2011; 12(8): 1269 doi: 10.1517/14656566.2011.549126
|
| 28 |
Macarena Simón-Talero, Rita García-Martínez, Maria Torrens, Salvador Augustin, Susana Gómez, Gustavo Pereira, Mónica Guevara, Pere Ginés, Germán Soriano, Eva Román, Jordi Sánchez-Delgado, Roser Ferrer, Juan C. Nieto, Pilar Sunyé, Inma Fuentes, Rafael Esteban, Juan Córdoba. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: A randomized double-blind study. Journal of Hepatology 2013; 59(6): 1184 doi: 10.1016/j.jhep.2013.07.020
|
| 29 |
Alastair J O'Brien, James N Fullerton, Karen A Massey, Grace Auld, Gavin Sewell, Sarah James, Justine Newson, Effie Karra, Alison Winstanley, William Alazawi, Rita Garcia-Martinez, Joan Cordoba, Anna Nicolaou, Derek W Gilroy. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nature Medicine 2014; 20(5): 518 doi: 10.1038/nm.3516
|
| 30 |
Roberta Gagliardi, Nicola Zeni, Salvatore Piano. Intravenous albumin in cirrhosis: Updated clinical uses and novel perspectives. Annals of Hepatology 2023; 28(6): 101150 doi: 10.1016/j.aohep.2023.101150
|
| 31 |
Zhaohui Bai, Le Wang, Ran Wang, Meijuan Zou, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, Gang Cheng, Xingshun Qi. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials. Hepatology International 2022; 16(6): 1468 doi: 10.1007/s12072-022-10374-z
|
| 32 |
Mauro Bernardi, Giacomo Zaccherini, Paolo Caraceni. Pro: The Role of Albumin in Pre–Liver Transplant Management. Liver Transplantation 2019; 25(1): 128 doi: 10.1002/lt.25356
|
| 33 |
Bianca Boff Sandi, Gabriel Stefani Leão, Angelo Alves de Mattos, Ângelo Zambam de Mattos. Long‐term albumin administration in patients with cirrhosis and ascites: A meta‐analysis of randomized controlled trials. Journal of Gastroenterology and Hepatology 2021; 36(3): 609 doi: 10.1111/jgh.15253
|
| 34 |
Mauro Bernardi, Carmen S. Ricci, Giacomo Zaccherini. Role of Human Albumin in the Management of Complications of Liver Cirrhosis. Journal of Clinical and Experimental Hepatology 2014; 4(4): 302 doi: 10.1016/j.jceh.2014.08.007
|
| 35 |
Guadalupe Garcia-Tsao. Long-term albumin in cirrhosis: is it the ANSWER?. The Lancet 2018; 391(10138): 2391 doi: 10.1016/S0140-6736(18)30948-6
|
| 36 |
F. Wong. Liver Cirrhosis: From Pathophysiology to Disease Management. 2008; 162: 248 doi: 10.1007/978-1-4020-8656-4_23
|
| 37 |
Kazuhisa Uchiyama, Kazunari Mori, Katsuyoshi Tabuse, Masaki Ueno, Satoru Ozawa, Takayuki Nakase, Manabu Kawai, Masaji Tani, Hiroshi Tanimura, Hiroki Yamaue. Assessment of liver function for successful hepatectomy in patients with hepatocellular carcinoma with impaired hepatic function. Journal of Hepato-Biliary-Pancreatic Surgery 2008; 15(6): 596 doi: 10.1007/s00534-007-1326-2
|
| 38 |
Rosa G Simonetti, Giovanni Perricone, Dimitrinka Nikolova, Goran Bjelakovic, Christian Gluud. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD004039.pub2
|
| 39 |
J. Boldt. Querschnittleitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten: Humanalbumin. Der Anaesthesist 2010; 59(6): 566 doi: 10.1007/s00101-010-1734-6
|
| 40 |
Isao Sakaida. Tolvaptan for the treatment of liver cirrhosis oedema. Expert Review of Gastroenterology & Hepatology 2014; 8(5): 461 doi: 10.1586/17474124.2014.903797
|
| 41 |
Jürgen Schölmerich. Medizinische Therapie 2007 | 2008. 2007; : 941 doi: 10.1007/978-3-540-48554-4_81
|
| 42 |
|
| 43 |
Bruce A. Runyon. Management of adult patients with ascites due to cirrhosis. Hepatology 2009; 49(6): 2087 doi: 10.1002/hep.22853
|
| 44 |
Jonel Trebicka, Guadalupe Garcia-Tsao. Controversies regarding albumin therapy in cirrhosis. Hepatology 2023; doi: 10.1097/HEP.0000000000000521
|
| 45 |
Wesley Leung, Florence Wong. Hepatorenal Syndrome: Do the Vasoconstrictors Work?. Gastroenterology Clinics of North America 2011; 40(3): 581 doi: 10.1016/j.gtc.2011.06.011
|
| 46 |
Paolo Caraceni, Marco Pavesi, Maurizio Baldassarre, Mauro Bernardi, Vicente Arroyo. The use of human albumin in patients with cirrhosis: a European survey. Expert Review of Gastroenterology & Hepatology 2018; 12(6): 625 doi: 10.1080/17474124.2018.1460203
|
| 47 |
Hitoshi Yoshiji. Management of cirrhotic ascites: Seven‐step treatment protocol based on the Japanese evidence‐based clinical practice guidelines for liver cirrhosis 2020. Hepatology Research 2023; 53(9): 794 doi: 10.1111/hepr.13937
|
| 48 |
Taichuan Xu, Wanjiang Liu, Ruizhen Huang. Can albumin reduce the mortality of patients with cirrhosis and ascites? A meta-analysis of randomized controlled trials. European Journal of Gastroenterology & Hepatology 2023; 35(1): 80 doi: 10.1097/MEG.0000000000002447
|
| 49 |
J. Boldt. RETRACTED: Use of albumin: an update. British Journal of Anaesthesia 2010; 104(3): 276 doi: 10.1093/bja/aep393
|
| 50 |
Yang He, Tingting Ning, Tingting Xie, Qingchuan Qiu, Liping Zhang, Yunfang Sun, Daiming Jiang, Kai Fu, Fei Yin, Wenjing Zhang, Lang Shen, Hui Wang, Jianjun Li, Qishan Lin, Yunxia Sun, Hongzhen Li, Yingguo Zhu, Daichang Yang. Large-scale production of functional human serum albumin from transgenic rice seeds. Proceedings of the National Academy of Sciences 2011; 108(47): 19078 doi: 10.1073/pnas.1109736108
|
| 51 |
Francesco Salerno, Massimo Cazzaniga, Silvia Accordino. May vaptans contribute to the treatment of refractory ascites?. Journal of Hepatology 2010; 53(2): 225 doi: 10.1016/j.jhep.2010.04.003
|
| 52 |
M. Bernardi, C. Maggioli, G. Zaccherini. Annual Update in Intensive Care and Emergency Medicine 2012. 2012; : 421 doi: 10.1007/978-3-642-25716-2_39
|
| 53 |
Nikhilesh R. Mazumder, Kofi Atiemo, Matthew Kappus, Giuseppe Cullaro, Matthew E. Harinstein, Daniela Ladner, Elizabeth Verna, Jennifer Lai, Josh Levitsky. A Comprehensive Review of Outcome Predictors in Low MELD Patients. Transplantation 2020; 104(2): 242 doi: 10.1097/TP.0000000000002956
|
| 54 |
Hengo Haljamäe. Alternatives to Blood Transfusion in Transfusion Medicine. 2010; : 119 doi: 10.1002/9781444319583.ch10
|
| 55 |
Kurt Lenz, Robert Buder, Lisbeth Kapun, Martin Voglmayr. Treatment and management of ascites and hepatorenal syndrome: an update. Therapeutic Advances in Gastroenterology 2015; 8(2): 83 doi: 10.1177/1756283X14564673
|
| 56 |
Huanhuan Tan, Yanting Ji, Hexu Lei, Fangyu Wang, Huan Dong, Shifeng Yang, Hongji Zhou, Hanxin Deng, Siyu Chen, David L. Kaplan, Qingyou Xia, Feng Wang. Large-scale and cost-effective production of recombinant human serum albumin (rHSA) in transgenic Bombyx mori cocoons. International Journal of Biological Macromolecules 2023; 245: 125527 doi: 10.1016/j.ijbiomac.2023.125527
|
| 57 |
Long-Bin Jeng, Tsai-Chung Li, Shih-Chao Hsu, Wen-Ling Chan, Chiao-Fang Teng. Association of Low Serum Albumin Level with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection. Journal of Clinical Medicine 2021; 10(18): 4187 doi: 10.3390/jcm10184187
|
| 58 |
Junjie Yao, Xianbin Xu, Kai Gong, Huilan Tu, Zhaoyu Xu, Shaoheng Ye, Xia Yu, Yan Lan, Haoda Weng, Yu Shi. Prognostic value of neutrophil count to albumin ratio in patients with decompensated cirrhosis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44842-9
|
| 59 |
Amine Benmassaoud, Suzanne C Freeman, Davide Roccarina, Maria Corina Plaz Torres, Alex J Sutton, Nicola J Cooper, Laura Iogna Prat, Maxine Cowlin, Elisabeth Jane Milne, Neil Hawkins, Brian R Davidson, Chavdar S Pavlov, Douglas Thorburn, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews 2020; doi: 10.1002/14651858.CD013123.pub2
|
| 60 |
Rakesh Kumar Jagdish, Jaswinder Singh Maras, Shiv Kumar Sarin. Albumin in Advanced Liver Diseases: The Good and Bad of a Drug!. Hepatology 2021; 74(5): 2848 doi: 10.1002/hep.31836
|
| 61 |
Farshad Abedi, Batool Zarei, Sepideh Elyasi. Albumin: a comprehensive review and practical guideline for clinical use. European Journal of Clinical Pharmacology 2024; 80(8): 1151 doi: 10.1007/s00228-024-03664-y
|
| 62 |
Akito Nozaki, Satoshi Yasumura, Tomohiko Sato, Asashi Tanaka, Yuji Yonemura, Koji Matsuzaki, Takehiro Kohno, Yuji Shimura, Shigeyoshi Makino, Masanori Matsumoto. EVIDENCE-BASED GUIDELINES FOR THE USE OF ALBUMIN PRODUCTS (REVISED THIRD EDITION). Japanese Journal of Transfusion and Cell Therapy 2024; 70(3): 406 doi: 10.3925/jjtc.70.406
|
| 63 |
Praveen Sharma, Pankaj Puri, Naresh Bansal, Vikas Singla, Ashish Kumar, Anil Anikhindi ShriHari, Anil Arora. Midodrine and albumin versus albumin alone for the secondary prophylaxis of acute kidney injury in a patient with cirrhosis and ascites. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e499 doi: 10.1097/MEG.0000000000002154
|
| 64 |
Rosaria Spinella, Rohit Sawhney, Rajiv Jalan. Albumin in chronic liver disease: structure, functions and therapeutic implications. Hepatology International 2016; 10(1): 124 doi: 10.1007/s12072-015-9665-6
|
| 65 |
Ray W. Kim, Karthik Raghunathan, Greg S. Martin, E. Anne Davis, Navreet S. Sindhwani, Santosh Telang, Kunal Lodaya. Timely Albumin Improves Survival in Patients With Cirrhosis on Diuretic Therapy Who Develop Acute Kidney Injury: Real-World Evidence in the United States. Gastro Hep Advances 2023; 2(2): 252 doi: 10.1016/j.gastha.2022.10.008
|
| 66 |
Nicholas Hannah, Douglas Tjandra, Ashwin Patwardhan, Kelsey Rutland, John Halliday, Siddharth Sood. Outpatient albumin infusions reduce hospitalizations and improve outcomes in decompensated cirrhosis: A real‐world cohort study. JGH Open 2023; 7(8): 537 doi: 10.1002/jgh3.12944
|
| 67 |
Marco Di Pascoli, Silvano Fasolato, Salvatore Piano, Massimo Bolognesi, Paolo Angeli. Long‐term administration of human albumin improves survival in patients with cirrhosis and refractory ascites. Liver International 2019; 39(1): 98 doi: 10.1111/liv.13968
|
| 68 |
Isadora Z. Bombassaro, Cristiane V. Tovo, Ângelo Z. de Mattos, Marcelo Ahlert, Talita Chiesa, Angelo A. de Mattos. Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysis. Annals of Hepatology 2021; 26: 100541 doi: 10.1016/j.aohep.2021.100541
|
| 69 |
Christian J Wiedermann, Stefan Dunzendorfer, Luigi U Gaioni, Francesco Zaraca, Michael Joannidis. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Critical Care 2010; 14(5) doi: 10.1186/cc9308
|
| 70 |
Rafael Bañares, Mauro Bernardi. Long‐term albumin administration in patients with decompensated cirrhosis. It is time for a reappraisal. Liver International 2019; 39(1): 45 doi: 10.1111/liv.13996
|
| 71 |
Patricia Huelin, Jose Ignacio Fortea, Javier Crespo, Emilio Fábrega. Ascites - Physiopathology, Treatment, Complications and Prognosis. 2017; doi: 10.5772/intechopen.70384
|
| 72 |
Deepanshu Khanna, Premashis Kar, Pabitra Sahu. Efficacy of long-term albumin therapy in the treatment of decompensated cirrhosis. Indian Journal of Gastroenterology 2024; 43(2): 494 doi: 10.1007/s12664-024-01566-6
|
| 73 |
Paolo Caraceni, Paolo Angeli, Daniele Prati, Mauro Bernardi, Carlo Alessandria, Oliviero Riggio, Francesco Salerno, Giancarlo Maria Liumbruno, Francesco Bennardello, Pierluigi Piccoli, Claudio Velati, Pierluigi Berti, Giuseppina Facco, Francesco Fiorin. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis. Digestive and Liver Disease 2016; 48(1): 4 doi: 10.1016/j.dld.2015.11.008
|
| 74 |
P.F.W. Strengers, E. van Twuijver. . Side Effects of Drugs Annual 2009; 31: 527 doi: 10.1016/S0378-6080(09)03133-X
|
| 75 |
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications . Clinical and Molecular Hepatology 2018; 24(3): 230 doi: 10.3350/cmh.2018.1005
|
| 76 |
Hypoalbuminemia in COVID-19: Molecular and Mechanistic Approach. Albus Scientia 2023; 2023(1): 1 doi: 10.56512/AS.2023.1.e230606
|
| 77 |
Paolo Caraceni, Alastair O’Brien, Pere Gines. Long-term albumin treatment in patients with cirrhosis and ascites. Journal of Hepatology 2022; 76(6): 1306 doi: 10.1016/j.jhep.2022.03.005
|
| 78 |
Fredric D. Gordon. Ascites. Clinics in Liver Disease 2012; 16(2): 285 doi: 10.1016/j.cld.2012.03.004
|
| 79 |
Mauro Bernardi, Paolo Angeli, Joan Claria, Richard Moreau, Pere Gines, Rajiv Jalan, Paolo Caraceni, Javier Fernandez, Alexander L Gerbes, Alastair J O'Brien, Jonel Trebicka, Thierry Thevenot, Vicente Arroyo. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut 2020; 69(6): 1127 doi: 10.1136/gutjnl-2019-318843
|
| 80 |
Shuet Fong Neong, Danielle Adebayo, Florence Wong. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites. Expert Review of Gastroenterology & Hepatology 2019; 13(4): 293 doi: 10.1080/17474124.2018.1555469
|
| 81 |
Yu Jun Wong, Rahul Kumar, Yu Jing Jonathan Chua, Tiing Leong Ang. Long-term albumin infusion in decompensated cirrhosis: A review of current literature . World Journal of Hepatology 2021; 13(4): 421-432 doi: 10.4254/wjh.v13.i4.421
|
| 82 |
Anas A. Ashour, Mohamed A. Atta, Khaled W. Sadek, Koutaibah R. Obaid, Mohammed Awad Ashour, Amr Ashour, Mohammed I. Danjuma, Suhail A. Doi, Abdel-Naser ElZouki. Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update. European Journal of Gastroenterology & Hepatology 2021; 33(4): 479 doi: 10.1097/MEG.0000000000001932
|
| 83 |
Guadalupe Garcia-Tsao, Juan G. Abraldes, Nicole E. Rich, Vincent Wai-Sun Wong. AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review. Gastroenterology 2024; 166(1): 202 doi: 10.1053/j.gastro.2023.10.016
|
| 84 |
Koichi Kozaki, Masahiro IInuma, Tomoyuki Takagi, Takanori Fukuda, Takaya Sanpei, Yusuke Terunuma, Yoshiharu Yatabe, Kazuhiro Akano. Cell‐Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver Cirrhosis. Therapeutic Apheresis and Dialysis 2016; 20(4): 376 doi: 10.1111/1744-9987.12469
|
| 85 |
Elsa Solà, Cristina Solé, Pere Ginès. New Strategies for the Management of Decompensated Cirrosis. Hepatology 2019; 69(5): 2289 doi: 10.1002/hep.30357
|
| 86 |
Jia-Xing Yang, Yue-Ming Peng, Hao-Tian Zeng, Xi-Min Lin, Zheng-Lei Xu. Drainage of ascites in cirrhosis. World Journal of Hepatology 2024; 16(9): 1245-1257 doi: 10.4254/wjh.v16.i9.1245
|
| 87 |
Lin Sun, PingPing Ding, WeiLin Mao, JianPing Wu, Ahmet Özer Sehirli. D-Dimer-to-Albumin Ratio: A Novel Indicator to Predict Poor Outcomes in Patients with HBV-Associated Decompensated Cirrhosis. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/9062383
|
| 88 |
|
| 89 |
Sayma Chaibi, Edouard Larrey, Jean Pierre Couty, Philippe Sultanik, Claudia Campani, Lorraine Blaise, Mathilde Wagner, Chantal Desdouets, Jean Charles Nault, Dominique Thabut, Manon Allaire. Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC. Clinics and Research in Hepatology and Gastroenterology 2023; 47(8): 102199 doi: 10.1016/j.clinre.2023.102199
|
| 90 |
Tyree H. Kiser, Robert MacLaren, Douglas N. Fish. Treatment of Hepatorenal Syndrome. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2009; 29(10): 1196 doi: 10.1592/phco.29.10.1196
|
| 91 |
Paolo Caraceni, Marco Domenicali, Alessandra Tovoli, Lucia Napoli, Carmen Serena Ricci, Manuel Tufoni, Mauro Bernardi. Clinical indications for the albumin use: Still a controversial issue. European Journal of Internal Medicine 2013; 24(8): 721 doi: 10.1016/j.ejim.2013.05.015
|
| 92 |
Gennaro D'Amico, Alberto Morabito, Mario D'Amico, Linda Pasta, Giuseppe Malizia, Paola Rebora, Maria Grazia Valsecchi. Clinical states of cirrhosis and competing risks. Journal of Hepatology 2018; 68(3): 563 doi: 10.1016/j.jhep.2017.10.020
|
| 93 |
Ângelo Zambam de Mattos, Douglas Alano Simonetto, Carlos Terra, Alberto Queiroz Farias, Paulo Lisboa Bittencourt, Tales Henrique Soares Pase, Marlon Rubini Toazza, Angelo Alves de Mattos, Alliance of Brazilian Centers for Cirrhosis Care – the ABC Group. Albumin administration in patients with cirrhosis: Current role and novel perspectives. World Journal of Gastroenterology 2022; 28(33): 4773-4786 doi: 10.3748/wjg.v28.i33.4773
|
| 94 |
Anand V. Kulkarni, Madhumita Premkumar, Juan P. Arab, Karan Kumar, Mithun Sharma, Nageshwar D. Reddy, Nagaraja R. Padaki, Rajender K. Reddy. Early Diagnosis and Prevention of Infections in Cirrhosis. Seminars in Liver Disease 2022; 42(03): 293 doi: 10.1055/a-1869-7607
|
| 95 |
Salvatore Piano, Thomas Reiberger, Hélène Larrue, Christophe Bureau. Portal Hypertension VII. 2022; : 549 doi: 10.1007/978-3-031-08552-9_49
|
| 96 |
Shashideep Singhal, Kiran K. Baikati, Ibrahim I. Jabbour, Sury Anand. Management of Refractory Ascites. American Journal of Therapeutics 2012; 19(2): 121 doi: 10.1097/MJT.0b013e3181ff7a8b
|
| 97 |
Jason W. Pinchot, Sanjeeva P. Kalva, Bill S. Majdalany, Charles Y. Kim, Osmanuddin Ahmed, Sumeet K. Asrani, Brooks D. Cash, Jens Eldrup-Jorgensen, A. Tuba Kendi, Matthew J. Scheidt, David M. Sella, Karin E. Dill, Eric J. Hohenwalter. ACR Appropriateness Criteria® Radiologic Management of Portal Hypertension. Journal of the American College of Radiology 2021; 18(5): S153 doi: 10.1016/j.jacr.2021.02.013
|
| 98 |
Liren Zhang, Weibin Yu, Yuwu Zhao, Xiaohua Chen, Peng Wang, Xiaohong Fan, Zhouwei Xu. Albumin Infusion May Improve the Prognosis of Critical COVID-19 Patients with Hypoalbuminemia in the Intensive Care Unit: A Retrospective Cohort Study. Infection and Drug Resistance 2022; : 6039 doi: 10.2147/IDR.S383818
|
| 99 |
A.B. Johan Groeneveld, Roberta J. Navickis, Mahlon M. Wilkes. Update on the Comparative Safety of Colloids. Annals of Surgery 2011; 253(3): 470 doi: 10.1097/SLA.0b013e318202ff00
|
| 100 |
Juan Uriz Otano, Soraya López López, Conrado Fernández Rodríguez. SHOULD WE INCORPORATE LONG-TERM USE OF ALBUMIN IN PATIENTS WITH DECOMPENSATED CIRRHOSIS IN OUR DAILY CLINICAL PRACTICE?. Revista Española de Enfermedades Digestivas 2022; 115 doi: 10.17235/reed.2022.9216/2022
|
| 101 |
Elsa Solà, Pere Ginès. Renal and circulatory dysfunction in cirrhosis: Current management and future perspectives. Journal of Hepatology 2010; 53(6): 1135 doi: 10.1016/j.jhep.2010.08.001
|
| 102 |
Marta Martín–Llahí, Marie–Noëlle Pépin, Mónica Guevara, Fernando Díaz, Aldo Torre, Alberto Monescillo, Germán Soriano, Carlos Terra, Emilio Fábrega, Vicente Arroyo, Juan Rodés, Pere Ginès. Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study. Gastroenterology 2008; 134(5): 1352 doi: 10.1053/j.gastro.2008.02.024
|
| 103 |
Ya-wu Zhang, Feng-xian Wei, Zhen-gang Wei, Gen-nian Wang, Man-cai Wang, You-cheng Zhang. Elective Splenectomy Combined with Modified Hassab’s or Sugiura Procedure for Portal Hypertension in Decompensated Cirrhosis. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/1208614
|
| 104 |
Mauro Bernardi, Caterina Maggioli, Giacomo Zaccherini. Human albumin in the management of complications of liver cirrhosis. Critical Care 2012; 16(2) doi: 10.1186/cc11218
|
| 105 |
Zhong Han, Xia He, SongQing Peng. Neutrophil count to albumin ratio as a prognostic indicator for HBV‐associated decompensated cirrhosis. Journal of Clinical Laboratory Analysis 2021; 35(4) doi: 10.1002/jcla.23730
|
| 106 |
Satoshi Yasumura, Shigeyoshi Makino, Masanori Matsumoto, Takehiro Kono, Shuichi Kino, Asashi Tanaka, Akemi Wakisaka, Yuji Yonemura, Tadashi Matsushita. Evidence-based Guidelines for the Use of Albumin Products Japan Society of Transfusion Medicine and Cell Therapy. Japanese Journal of Transfusion and Cell Therapy 2017; 63(5): 641 doi: 10.3925/jjtc.63.641
|
| 107 |
Saqib Walayat, Daniel Martin, Jaymon Patel, Umair Ahmed, Muhammad N. Asghar, Aparna U. Pai, Sonu Dhillon. Role of albumin in cirrhosis: from a hospitalist’s perspective. Journal of Community Hospital Internal Medicine Perspectives 2017; 7(1): 8 doi: 10.1080/20009666.2017.1302704
|
| 108 |
Yoshihiro Onishi, Takafumi Wakita, Shinichi Fukuhara, Yoshinori Noguchi, Mitsuru Okada, Isao Sakaida, Yutaka Sasaki, Kenji Kobayashi. Development and Validation of a Symptom Scale Specific for Ascites Accompanied with Cirrhosis: The ASI-7. Clinical and Translational Gastroenterology 2014; 5(2): e48 doi: 10.1038/ctg.2013.20
|
| 109 |
Jiarong Zhang, Wei Pei, Qilan Xu, Huijun Jiang, Jin Chen. Desolvation-induced formation of recombinant camel serum albumin-based nanocomposite for glutathione colorimetric determination. Sensors and Actuators B: Chemical 2022; 357: 131417 doi: 10.1016/j.snb.2022.131417
|
| 110 |
Sophie E. Claudel, Jeeva Jaganathan, Ankit Patel, Elliot B. Tapper, Ashish Verma. Review article: Practical considerations for fluid resuscitation in cirrhosis. Alimentary Pharmacology & Therapeutics 2023; 57(10): 1066 doi: 10.1111/apt.17458
|
| 111 |
Use of albumin infusion for cirrhosis-related complications: An international position statement. JHEP Reports 2023; 5(8): 100785 doi: 10.1016/j.jhepr.2023.100785
|
| 112 |
|
| 113 |
Sebastiano Buccheri, Ben L. Da. Hepatorenal Syndrome. Clinics in Liver Disease 2022; 26(2): 181 doi: 10.1016/j.cld.2022.01.002
|
| 114 |
Mauro Bernardi, Paolo Caraceni. Novel perspectives in the management of decompensated cirrhosis. Nature Reviews Gastroenterology & Hepatology 2018; 15(12): 753 doi: 10.1038/s41575-018-0045-2
|